Contact

Clear Ember Home About Services What Is Ibogaine Evidence & Trials Safety & Considerations Contact Evidence first / uncertainty included Ibogaine For Alcoholism Ibogaine for alcoholism is an experimental approach—not an approved therapy—and the alcohol-specific human evidence remains limited. Clear context over promises: what is known, what is being tested, and why safety cannot be treated as an afterthought. The plain version Ibogaine is a psychoactive alkaloid derived from the African shrub Tabernanthe iboga . It is being studied in addiction research, including alcohol use disorder. What people mean by ibogaine for alcoholism In this context, “ibogaine for alcoholism” usually means direct use of ibogaine itself, use of noribogaine or another derivative such as DMX-1001, or a clinic package combining the drug with detox, monitoring, and integration therapy. The general definition of ibogaine helps distinguish the compound from the broader programs that may be marketed around it. The evidence base for alcohol use disorder is much thinner than the evidence often discussed for opioids. A Brazilian pilot reported feasibility and some reduction in alcohol consumption, but the literature still lacks a completed, convincing randomized trial for alcoholism. An overview of animal alcohol-intake findings does not substitute for proof of clinical benefit in people. The numbers need context. Small studies and non-AUD findings are often repeated in treatment marketing. They should not be treated as settled clinical evidence. 12 Planned alcohol trial patients The Brazilian alcoholism trial NCT03380728 planned or enrolled 12 alcoholic patients in an open-label, escalating-dose design. Each patient was to be hospitalized for 20 days and receive three increasing doses. 9 Adults in a USP pilot A USP pilot in severe alcohol use disorder included nine adults. Two of nine volunteers were abstinent from alcohol and other drugs at three months of follow-up; eight of nine also ha

Contact

A place for useful feedback.